Press releases
- Relmada Therapeutics to Participate in the 2023 Jefferies Global Healthcare Conference
- Relmada Therapeutics to Present Data at the American Society of Clinical Psychopharmacology 2023 Annual Meeting
- Relmada Therapeutics Provides Corporate Update and Reports First Quarter 2023 Financial Results
- Relmada Therapeutics to Report First Quarter 2023 Financial Results and Host Conference Call and Webcast on May 11, 2023
- Relmada Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2022 Financial Results
- Relmada Therapeutics to Report Fourth Quarter and Full-Year 2022 Financial Results and Host Conference Call and Webcast on March 23, 2023
More ▼
Key statistics
As of last trade, Relmada Therapeutics Inc (4E2:STU) traded at 2.62, 35.75% above the 52 week low of 1.93 set on Mar 24, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.62 |
---|---|
High | 2.66 |
Low | 2.56 |
Bid | 2.60 |
Offer | 2.70 |
Previous close | 2.62 |
Average volume | 0.00 |
---|---|
Shares outstanding | 30.10m |
Free float | 29.71m |
P/E (TTM) | -- |
Market cap | 85.78m USD |
EPS (TTM) | -4.78 USD |
Data delayed at least 15 minutes, as of Jun 06 2023.
More ▼